Table 1 One-way analysis of variance and trend analysis showing volatile metabolites that have concentration–response relationships with particle exposure.

From: A novel lung alveolar cell model for exploring volatile biomarkers of particle-induced lung injury

Compound

CAS no.

Non-exposed control

200 μg/mL

500 μg/mL

p for trend

Mean (SE)

Mean (SE)

Mean (SE)

Principal component 1

1,2,4-Oxadiazole, 5-(4-nitrophenyl)-3-phenyl-

28825-12-9

0.80 (0.41)

0.87 (0.10)

1.18 (0.22)

0.40

2,6-Dimethyl-6-trifluoroacetoxyoctane

61986-67-2

7.51 (1.86)

8.55 (2.06)

10.58 (1.61)

0.32

Principal component 2

3-Buten-1-amine, N,N-dimethyl-

55831-89-5

1.27 (0.72)

2.45 (0.65)

17.69 (9.13)

0.049*

2-Propanol, 2-methyl-

75-65-0

1.87 (0.81)

2.56 (0.62)

12.31 (6.69)

0.08

Glycolaldehyde dimethyl acetal

30934-97-5

0.43 (0.25)

8.25 (2.53)

9.55 (3.07)

0.02*

Propanoic acid, 2-oxo-, ethyl ester

617-35-6

0.23 (0.09)

0.25 (0.06)

0.73 (0.34)

0.11

Octane

111-65-9

0.96 (0.26)

1.54 (0.35)

5.26 (2.50)

0.06

Octane, 3,3-dimethyl-

4110-44-5

1.43 (0.79)

1.66 (0.30)

10.05 (4.52)

0.04*

Heptane, 2,3-dimethyl-

3074-71-3

0.19 (0.09)

0.47 (0.04)

2.58 (1.02)

0.01*

Ethanedioic acid, bis(trimethylsilyl) ester

18294-04-7

2.93 (1.06)

6.56 (1.91)

9.81 (2.59)

0.03*

  1. *p-value < 0.05.